Wan Yong Ho Selected Research

eupatorin

1/2020	Eupatorin Suppressed Tumor Progression and Enhanced Immunity in a 4T1 Murine Breast Cancer Model.
1/2019	Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan Yong Ho Research Topics

Disease

22	Neoplasms (Cancer) 05/2022 - 01/2012
21	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2013
8	Inflammation (Inflammations) 03/2021 - 01/2013
8	Body Weight (Weight, Body) 01/2020 - 01/2015
6	Obesity 01/2020 - 01/2012
4	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 10/2021
1	Disease Progression 03/2021
1	Liver Diseases (Liver Disease) 03/2021
1	Insulin Resistance 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Hyperglycemia 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Carcinogenesis 01/2016
1	Atherosclerosis 01/2015
1	Chronic Disease (Chronic Diseases) 05/2014
1	Skin Diseases (Skin Disease) 06/2013

Drug/Important Bio-Agent (IBA)

13	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
5	damnacanthalIBA 09/2016 - 08/2013
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
4	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020 - 01/2017
4	CytokinesIBA 01/2020 - 01/2013
3	AntioxidantsIBA 06/2018 - 01/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 09/2015
3	flavokawain BIBA 01/2017 - 10/2013
3	LipidsIBA 01/2017 - 01/2015
3	AnthraquinonesIBA 01/2015 - 08/2013
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2020
2	Estrogen ReceptorsIBA 02/2021 - 01/2021
2	CurcuminIBA 02/2021 - 01/2017
2	eupatorinIBA 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2013
2	NF-kappa B (NF-kB)IBA 01/2018 - 09/2015
2	AdipokinesIBA 01/2017 - 01/2017
2	Biological ProductsIBA 01/2015 - 06/2014
2	flavokawain AIBA 01/2014 - 10/2013
2	hydroxycitric acidIBA 01/2013 - 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 04/2021
1	TanninsIBA 03/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Circulating MicroRNAIBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	flavoneIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 12/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2018
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 06/2018
1	Silybin (Lagosa)IBA 06/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	EnzymesIBA 06/2017
1	SolutionsIBA 01/2017
1	Food IngredientsIBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2016
1	Therapeutic UsesIBA 09/2016
1	Tyrosine (L-Tyrosine)FDA Link 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016
1	Cytoskeletal ProteinsIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2015
1	BilirubinIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Alkaline PhosphataseIBA 01/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	3-bromo-1-hydroxy-9,10-anthraquinoneIBA 08/2013
1	nordamnacanthalIBA 08/2013
1	Interleukin-2 (IL2)IBA 01/2013
1	Interferon-gamma (Interferon, gamma)IBA 01/2013
1	Serotonin (5 Hydroxytryptamine)IBA 01/2013

Therapy/Procedure

5	Therapeutics 03/2021 - 05/2014
3	Drug Therapy (Chemotherapy) 12/2020 - 09/2016
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Radiotherapy 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2013
1	Chemoprevention 01/2013
1	Immunomodulation 01/2013
1	Traditional Medicine (Folk Remedies) 01/2012